129 related articles for article (PubMed ID: 23995153)
1. The metabolic syndrome in untreated schizophrenia patients: prevalence and putative mechanisms.
Reddy SM; Goudie CT; Agius M
Psychiatr Danub; 2013 Sep; 25 Suppl 2():S94-8. PubMed ID: 23995153
[TBL] [Abstract][Full Text] [Related]
2. [Drawing up guidelines for the attendance of physical health of patients with severe mental illness].
Saravane D; Feve B; Frances Y; Corruble E; Lancon C; Chanson P; Maison P; Terra JL; Azorin JM;
Encephale; 2009 Sep; 35(4):330-9. PubMed ID: 19748369
[TBL] [Abstract][Full Text] [Related]
3. Metabolic syndrome and cardiovascular risk among patients with schizophrenia receiving antipsychotics in Malaysia.
Said MA; Sulaiman AH; Habil MH; Das S; Bakar AK; Yusoff RM; Loo TH; Bakar SA
Singapore Med J; 2012 Dec; 53(12):801-7. PubMed ID: 23268153
[TBL] [Abstract][Full Text] [Related]
4. Atypical antipsychotic drugs, schizophrenia, and metabolic syndrome in non-Euro-American societies.
Bou Khalil R
Clin Neuropharmacol; 2012; 35(3):141-7. PubMed ID: 22592510
[TBL] [Abstract][Full Text] [Related]
5. CNR1 gene and risk of the metabolic syndrome in patients with schizophrenia.
Yu W; De Hert M; Moons T; Claes SJ; Correll CU; van Winkel R
J Clin Psychopharmacol; 2013 Apr; 33(2):186-92. PubMed ID: 23422373
[TBL] [Abstract][Full Text] [Related]
6. Genetic variants of microsomal triglyceride transfer protein (MTTP) are associated with metabolic syndrome in schizophrenic patients treated with atypical antipsychotics.
Liou YJ; Tsai SJ; Wang YC; Bai YM; Hong CJ
J Clin Psychopharmacol; 2013 Jun; 33(3):313-8. PubMed ID: 23609384
[TBL] [Abstract][Full Text] [Related]
7. The prevalence of metabolic syndrome and its association with alanine aminotransferase in clozapine-treated Korean patients with schizophrenia.
Lee NY; Roh MS; Kim SH; Jung DC; Yu HY; Sung KH; Chung IW; Youn T; Kang UG; Ahn YM; Kim YS
Int Clin Psychopharmacol; 2013 Mar; 28(2):71-9. PubMed ID: 23211493
[TBL] [Abstract][Full Text] [Related]
8. Body mass index as a screening test for metabolic syndrome in schizophrenia and schizoaffective disorders.
Tirupati S; Chua LE
Australas Psychiatry; 2007 Dec; 15(6):470-3. PubMed ID: 17999257
[TBL] [Abstract][Full Text] [Related]
9. Medical risk in patients with bipolar disorder and schizophrenia.
Newcomer JW
J Clin Psychiatry; 2006; 67 Suppl 9():25-30; discussion 36-42. PubMed ID: 16965186
[TBL] [Abstract][Full Text] [Related]
10. Prevalence and predictors of metabolic syndrome among patients attending an outpatient clozapine clinic in Australia.
Brunero S; Lamont S; Fairbrother G
Arch Psychiatr Nurs; 2009 Jun; 23(3):261-8. PubMed ID: 19446781
[TBL] [Abstract][Full Text] [Related]
11. Metabolic syndrome and obsessive-compulsive disorder: a naturalistic Italian study.
Albert U; Aguglia A; Chiarle A; Bogetto F; Maina G
Gen Hosp Psychiatry; 2013; 35(2):154-9. PubMed ID: 23158675
[TBL] [Abstract][Full Text] [Related]
12. Prevalence and predictors of metabolic syndrome in patients with schizophrenia and healthy controls: A study in rural South Indian population.
Rawat VS; Ganesh S; Bijjal S; Shanivaram Reddy K; Agarwal V; Devi R; Kumar CN; Christopher R; Thirthalli J
Schizophr Res; 2018 Feb; 192():102-107. PubMed ID: 28454923
[TBL] [Abstract][Full Text] [Related]
13. Prevalence of the metabolic syndrome in schizophrenic patients receiving second-generation antipsychotic agents--a cross-sectional study.
Kagal UA; Torgal SS; Patil NM; Malleshappa A
J Pharm Pract; 2012 Jun; 25(3):368-73. PubMed ID: 22551560
[TBL] [Abstract][Full Text] [Related]
14. Biological perspectives. Metabolic syndrome: schizophrenia and atypical antipsychotics.
Keltner NL
Perspect Psychiatr Care; 2006 Aug; 42(3):204-7. PubMed ID: 16916424
[No Abstract] [Full Text] [Related]
15. [Comorbidity of metabolic syndrome, diabetes and schizophrenia: theoretical and practical considerations].
Réthelyi J; Sawalhe AD
Orv Hetil; 2011 Mar; 152(13):505-11. PubMed ID: 21398211
[TBL] [Abstract][Full Text] [Related]
16. Associations between metabolic and aerobic fitness parameters in patients with schizophrenia.
Vancampfort D; Guelinkcx H; Probst M; Stubbs B; Rosenbaum S; Ward PB; De Hert M
J Nerv Ment Dis; 2015 Jan; 203(1):23-7. PubMed ID: 25494336
[TBL] [Abstract][Full Text] [Related]
17. Metabolic syndrome and schizophrenia from integrative medicine perspective.
Maslov B; Jakovljević M; Crncević Z; Ostojić L; Marcinko D; Babić D; Korsić M
Psychiatr Danub; 2008 Sep; 20(3):384-9. PubMed ID: 18827767
[TBL] [Abstract][Full Text] [Related]
18. Prevalence of the metabolic syndrome among schizophrenic patients hospitalized in the Canary Islands.
Sánchez-Araña Moreno T; Touriño González R; Hernández Fleta JL; León Pérez P
Actas Esp Psiquiatr; 2007; 35(6):359-67. PubMed ID: 18004674
[TBL] [Abstract][Full Text] [Related]
19. The metabolic syndrome and schizophrenia.
Meyer JM; Stahl SM
Acta Psychiatr Scand; 2009 Jan; 119(1):4-14. PubMed ID: 19133915
[TBL] [Abstract][Full Text] [Related]
20. Metabolic abnormalities among people diagnosed with schizophrenia: a literature review and implications for mental health nurses.
McDaid TM; Smyth S
J Psychiatr Ment Health Nurs; 2015 Apr; 22(3):157-70. PubMed ID: 25524393
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
